Cargando…

Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort

BACKGROUND: Long‐term population‐representative data on motor fluctuations and levodopa‐induced dyskinesias in Parkinson's disease is lacking. METHODS: The Cambridgeshire Parkinson's Incidence from GP to Neurologist (CamPaIGN) cohort comprises incident PD cases followed for up to 13 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Han‐Joon, Mason, Sarah, Foltynie, Thomas, Winder‐Rhodes, Sophie, Barker, Roger A., Williams‐Gray, Caroline H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063985/
https://www.ncbi.nlm.nih.gov/pubmed/31965629
http://dx.doi.org/10.1002/mds.27882
_version_ 1783504794482114560
author Kim, Han‐Joon
Mason, Sarah
Foltynie, Thomas
Winder‐Rhodes, Sophie
Barker, Roger A.
Williams‐Gray, Caroline H.
author_facet Kim, Han‐Joon
Mason, Sarah
Foltynie, Thomas
Winder‐Rhodes, Sophie
Barker, Roger A.
Williams‐Gray, Caroline H.
author_sort Kim, Han‐Joon
collection PubMed
description BACKGROUND: Long‐term population‐representative data on motor fluctuations and levodopa‐induced dyskinesias in Parkinson's disease is lacking. METHODS: The Cambridgeshire Parkinson's Incidence from GP to Neurologist (CamPaIGN) cohort comprises incident PD cases followed for up to 13 years (n = 141). Cumulative incidence of motor fluctuations and levodopa‐induced dyskinesias and risk factors were assessed using Kaplan‐Meyer and Cox regression analyses. RESULTS: Cumulative incidence of motor fluctuations and levodopa‐induced dyskinesias was 54.3% and 14.5%, respectively, at 5 years and 100% and 55.7%, respectively, at 10 years. Higher baseline UPDRS‐total and SNCA rs356219(A) predicted motor fluctuations, whereas higher baseline Mini‐mental State Examination and GBA mutations predicted levodopa‐induced dyskinesias. Early levodopa use did not predict motor complications. Both early motor fluctuations and levodopa‐induced dyskinesias predicted reduced mortality in older patients (age at diagnosis >70 years). CONCLUSIONS: Our data support the hypothesis that motor complications are related to the severity of nigrostriatal pathology rather than early levodopa use and indicate that early motor complications do not necessarily confer a negative prognosis. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
format Online
Article
Text
id pubmed-7063985
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-70639852020-03-16 Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort Kim, Han‐Joon Mason, Sarah Foltynie, Thomas Winder‐Rhodes, Sophie Barker, Roger A. Williams‐Gray, Caroline H. Mov Disord Brief Reports BACKGROUND: Long‐term population‐representative data on motor fluctuations and levodopa‐induced dyskinesias in Parkinson's disease is lacking. METHODS: The Cambridgeshire Parkinson's Incidence from GP to Neurologist (CamPaIGN) cohort comprises incident PD cases followed for up to 13 years (n = 141). Cumulative incidence of motor fluctuations and levodopa‐induced dyskinesias and risk factors were assessed using Kaplan‐Meyer and Cox regression analyses. RESULTS: Cumulative incidence of motor fluctuations and levodopa‐induced dyskinesias was 54.3% and 14.5%, respectively, at 5 years and 100% and 55.7%, respectively, at 10 years. Higher baseline UPDRS‐total and SNCA rs356219(A) predicted motor fluctuations, whereas higher baseline Mini‐mental State Examination and GBA mutations predicted levodopa‐induced dyskinesias. Early levodopa use did not predict motor complications. Both early motor fluctuations and levodopa‐induced dyskinesias predicted reduced mortality in older patients (age at diagnosis >70 years). CONCLUSIONS: Our data support the hypothesis that motor complications are related to the severity of nigrostriatal pathology rather than early levodopa use and indicate that early motor complications do not necessarily confer a negative prognosis. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. John Wiley & Sons, Inc. 2019-11-11 2020-01 /pmc/articles/PMC7063985/ /pubmed/31965629 http://dx.doi.org/10.1002/mds.27882 Text en © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Reports
Kim, Han‐Joon
Mason, Sarah
Foltynie, Thomas
Winder‐Rhodes, Sophie
Barker, Roger A.
Williams‐Gray, Caroline H.
Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort
title Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort
title_full Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort
title_fullStr Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort
title_full_unstemmed Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort
title_short Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort
title_sort motor complications in parkinson's disease: 13‐year follow‐up of the campaign cohort
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063985/
https://www.ncbi.nlm.nih.gov/pubmed/31965629
http://dx.doi.org/10.1002/mds.27882
work_keys_str_mv AT kimhanjoon motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort
AT masonsarah motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort
AT foltyniethomas motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort
AT winderrhodessophie motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort
AT barkerrogera motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort
AT williamsgraycarolineh motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort